SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-110957
Filing Date
2024-10-01
Accepted
2024-10-01 17:24:26
Documents
11
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20240930.htm   iXBRL 8-K 42239
  Complete submission text file 0000950170-24-110957.txt   152514

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20240930.xsd EX-101.SCH 23858
13 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20240930_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 241344471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)